ArticleMolecular therapy. Methods & clinical development2022

Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application.

Yuko Kitano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.